Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
ASMF, CA...
HRV Pharma - Market Expansion Leader in Pharmaceuticals.
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Sumar Biotech work together to Innovate & Manufacture Semi-synthetic, Synthetic & Fermentation API.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
GDUFA
DMF Review : Complete
Rev. Date : 2016-10-07
Pay. Date : 2016-05-11
DMF Number : 30467
Submission : 2016-06-29
Status :
Type : II
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
GDUFA
DMF Review : Complete
Rev. Date : 2020-11-05
Pay. Date : 2020-08-20
DMF Number : 33366
Submission : 2020-08-31
Status :
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Topical
Parenteral
Film Formers & Plasticizers
Solubilizers
Fillers, Diluents & Binders
Emulsifying Agents
Thickeners and Stabilizers
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
US Patents
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
27
PharmaCompass offers a list of Liraglutide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Liraglutide manufacturer or Liraglutide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Liraglutide manufacturer or Liraglutide supplier.
PharmaCompass also assists you with knowing the Liraglutide API Price utilized in the formulation of products. Liraglutide API Price is not always fixed or binding as the Liraglutide Price is obtained through a variety of data sources. The Liraglutide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Liraglutide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Liraglutide, including repackagers and relabelers. The FDA regulates Liraglutide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Liraglutide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Liraglutide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Liraglutide supplier is an individual or a company that provides Liraglutide active pharmaceutical ingredient (API) or Liraglutide finished formulations upon request. The Liraglutide suppliers may include Liraglutide API manufacturers, exporters, distributors and traders.
click here to find a list of Liraglutide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Liraglutide DMF (Drug Master File) is a document detailing the whole manufacturing process of Liraglutide active pharmaceutical ingredient (API) in detail. Different forms of Liraglutide DMFs exist exist since differing nations have different regulations, such as Liraglutide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Liraglutide DMF submitted to regulatory agencies in the US is known as a USDMF. Liraglutide USDMF includes data on Liraglutide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Liraglutide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Liraglutide suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Liraglutide Drug Master File in Korea (Liraglutide KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Liraglutide. The MFDS reviews the Liraglutide KDMF as part of the drug registration process and uses the information provided in the Liraglutide KDMF to evaluate the safety and efficacy of the drug.
After submitting a Liraglutide KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Liraglutide API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Liraglutide suppliers with KDMF on PharmaCompass.
A Liraglutide written confirmation (Liraglutide WC) is an official document issued by a regulatory agency to a Liraglutide manufacturer, verifying that the manufacturing facility of a Liraglutide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Liraglutide APIs or Liraglutide finished pharmaceutical products to another nation, regulatory agencies frequently require a Liraglutide WC (written confirmation) as part of the regulatory process.
click here to find a list of Liraglutide suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Liraglutide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Liraglutide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Liraglutide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Liraglutide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Liraglutide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Liraglutide suppliers with NDC on PharmaCompass.
Liraglutide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Liraglutide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Liraglutide GMP manufacturer or Liraglutide GMP API supplier for your needs.
A Liraglutide CoA (Certificate of Analysis) is a formal document that attests to Liraglutide's compliance with Liraglutide specifications and serves as a tool for batch-level quality control.
Liraglutide CoA mostly includes findings from lab analyses of a specific batch. For each Liraglutide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Liraglutide may be tested according to a variety of international standards, such as European Pharmacopoeia (Liraglutide EP), Liraglutide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Liraglutide USP).
